Unexplainable Nondermatomal Somatosensory Deficits in Patients
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cervical Schwannoma: Report of Four Cases
25-Cervical_3-PRIMARY.qxd 7/10/12 5:22 PM Page 345 CASE REPORT Cervical Schwannoma: Report of Four Cases Rohaizam Jaafar, MD (UKM), Tang Ing Ping, MS ORL-HNS (UM), Doris Evelyn Jong Yah Hui, MS ORL-HNS (UKM), Tan Tee Yong, MS ORL-HNS (UM), Mohammad Zulkarnaen Ahmad Narihan, MPATH (UKM) School of Health Sciences, Health Campus, Hospital Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia. SUMMARY Physical examination revealed a 3 x 3 cm mass located at Extracranial schwannomas in the head and neck region are right lateral upper third of the cervical region. The mass was rare neoplasms. The tumours often present as asymptomatic, firm, mobile and non-tender. She had a right facial nerve slowly enlarging lateral neck masses and determination of palsy (House-Brackman Grade IV) due to a previous operation the nerve origin is not often made until the time of surgery. for a right acoustic neuroma in 2000 and a right supraorbital Preoperative diagnosis maybe aided by imaging studies such wound for a plexiform schwannoma in 2007. as magnetic resonance imaging or computed tomography, while open biopsy is no longer recommended. The accepted A computed tomography of the neck and thorax was treatment for these tumors is surgical resection with performed and showed a well defined, minimally enhancing preservation of the neural pathway. We report four cases of lesion at the left parapharyngeal space measuring 2.4 x 4.3 x cervical schwannomas that we encountered at our center 10 cm. The left carotid sheath vessel is displaced medially. during four years of period. -
Case Report Head and Neck Schwannomas: a Surgical Challenge—A Series of 5 Cases
Hindawi Case Reports in Otolaryngology Volume 2018, Article ID 4074905, 10 pages https://doi.org/10.1155/2018/4074905 Case Report Head and Neck Schwannomas: A Surgical Challenge—A Series of 5 Cases Ishtyaque Ansari,1 Ashfaque Ansari,2 Arjun Antony Graison ,2 Anuradha J. Patil,3 and Hitendra Joshi2 1Department of Neurosurgery, MGM Medical College & Hospital, Aurangabad, India 2Department of ENT, MGM Medical College & Hospital, Aurangabad, India 3Department of Plastic Surgery, MGM Medical College & Hospital, Aurangabad, India Correspondence should be addressed to Arjun Antony Graison; [email protected] Received 25 September 2017; Accepted 29 January 2018; Published 4 March 2018 Academic Editor: Abrão Rapoport Copyright © 2018 Ishtyaque Ansari et al. +is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Schwannomas, also known as neurilemmomas, are benign peripheral nerve sheath tumors. +ey originate from any nerve covered with schwann cell sheath. Schwannomas constitute 25–45% of tumors of the head and neck. About 4% of head and neck schwannomas present as a sinonasal schwannoma. Brachial plexus schwannoma constitute only about 5% of schwannomas. Cervical vagal schwannomas constitute about 2–5% of neurogenic tumors. Methods. We present a case series of 5 patients of schwannomas, one arising from the maxillary branch of trigeminal nerve in the maxillary sinus, second arising from the brachial plexus, third arising from the cervical vagus, and two arising from cervical spinal nerves. Result. Complete extracapsular excision of the tumors was achieved by microneurosurgical technique with preservation of nerve of origin in all except one. -
Tumors of the Brachial Plexus (XI-1)
E. LOCAL SYNDROMES OF THE UPPER LIMBS AND RELATIVELY GENERALIZED SYNDROMES OF THE UPPER AND LOWER LIMBS GROUP XI: PAIN IN THE SHOULDER, ARM, AND HAND Tumors of the Brachial Plexus (XI-1) Definition Progressive aching, burning pain with paresthesias and sensory and motor impairment in the distribution of a branch or branches of the brachial plexus due to tumor. Site Shoulder and upper limb. System Nervous system. Tumors Benign tumors: schwannoma, neurofibroma. Malignant tumors: malignant schwannoma and fibrosarcoma, metastatic neoplasm or direct invasion from other lesion, neuroblastoma, ganglioneuroma (secondary neoplasia of peripheral nerves occurs frequently in lymphoma, leukemia, multiple myeloma). Breast, lung and thyroid neoplasia frequently involve the brachial plexus. Main Features Incidence: the specific tumors of peripheral nerve are extremely rare. Sex Ratio: there is no sex predilection. Age of Onset: young adulthood. They are more common with von Recklinghausen’s disease. Pain Quality: the pain tends to be constant, gradual in onset, aching, and burning, and associated with paresthesias in the distribution of the pain, progressive wasting of muscles depending upon what groups are involved, and sensory loss. Intensity: severe. Associated Symptoms The pain is generally not affected by activity. There is associated sensory loss and muscle wasting depending upon the area of the brachial plexus involved. Pain relief is often not adequate, even with significant narcotics. Signs and Laboratory Findings The laboratory findings are those of the underlying disease. Signs are loss of reflexes, sensation, and muscle strength in the distribution of the involved portion of the plexus. There may be a local mass. The diagnosis is usually made promptly by X-ray or by CT scan. -
Sciatic Neuropathy from a Giant Hibernoma of the Thigh: a Case Report
A Case Report & Literature Review Sciatic Neuropathy From a Giant Hibernoma of the Thigh: A Case Report Salim Ersozlu, MD, Orcun Sahin, MD, Ahmet Fevzi Ozgur, MD, and Tolga Akkaya, MD ibernomas—rare, uniformly benign soft-tissue the gastrocnemius/soleus, posterior tibialis, and toe flexors tumors of brown fat—were originally described (tibial nerve-innervated muscles); and sensory abnormali- in 1906 by Merkel.1 These tumors are usually ties throughout the entire sciatic nerve distribution. The found in the scapular2 and posterior cervical common peroneal, posterior tibial, superficial peroneal, Hregions or (more rarely) in the folds of the buttocks or on and sural nerves were electrodiagnostically evaluated, and the thigh.3-5 reduced amplitude in the peroneal and the tibialis poste- Sciatic neuropathy is an infrequently diagnosed focal rior nerves was detected. Sensory nerve conduction of the mononeuropathy. Few case reports of lipomas compressing superficial peroneal and sural nerves in the left leg was the sciatic nerve or its peripheral branches have appeared in less than that in the right leg. These findings confirmed the literature.6-8 The present case report is to our knowledge active motor and sensory sciatic mononeuropathy of the the first on sciatic nerve palsy caused by a hibernoma. left leg. Plain x-rays of the left leg showed a large soft-tissue CASE REPORT mass without calcification. Magnetic resonance imaging A woman in her early 30s was referred to our clinic with a (MRI) of the left leg revealed a well-circumscribed large painless left-side posterior thigh mass that had been slowly soft-tissue mass that was 27 cm at its maximum dimen- enlarging over 5 years. -
Numb Chin Sydrome : a Subtle Clinical Condition with Varied Etiology
OLGU SUNUMU / CASE REPORT Gülhane Tıp Derg 2015;57: 324 - 327 © Gülhane Askeri Tıp Akademisi 2015 doi: 10.5455/gulhane.44276 Numb chin sydrome : A subtle clinical condition with varied etiology Devika SHETTY (*), Prashanth SHENAI (**), Laxmikanth CHATRA (**), KM VEENA (**), Prasanna Kumar RAO (**), Rachana V PRABHU (**), Tashika KUSHRAJ (**) SUMMARY Introduction One of the rare neurologic symptoms characterized by hypoesthesia or Numb Chin Syndrome (NCS) is a sensory neuropathy cha- paresthesia of the chin and the lower lip, limited to the region served by the mental nerve is known as Numb chin syndrome. Vast etiologic factors have been racterized by altered sensation and numbness in the distribu- implicated in the genesis of numb chin syndrome. Dental, systemic and malignant tion of the mental nerve, a terminal branch of the mandibular etiologies have been well documented. We present a case of a 59 year old female patient who reported with all the classical features of numb chin syndrome. On division of trigeminal nerve. Any dysfunction along the course magnetic resonance imaging, the vascular compression of the trigeminal nerve of trigeminal nerve and its branches, intracranially and ext- root was evident which has been infrequently documented to be associated with racranially either by direct injury or compression of the nerve the condition. We have also briefly reviewed the etiology and pathogenesis of 1 numb chin syndrome and also stressed on the importance of magnetic resonance can predispose to NCS. Various etiologic factors have been imaging as an investigative modality in diagnosing the condition. considered of which dental procedures and dental pathologies Key Words: Numb Chin Syndrome, Mental nerve neuropathy, trigeminal nerve root, are the most common benign causes. -
COVID-19 Vaccine (Vero Cell), Inactivated (Sinopharm) Manufacturer: Beijing Institute of Biological Products Co., Ltd
COVID-19 Vaccine Explainer 24 MAY 20211 COVID-19 Vaccine (Vero Cell), Inactivated (Sinopharm) Manufacturer: Beijing Institute of Biological Products Co., Ltd The SARS-CoV-2 Vaccine (VeroCell) is an inactivated vaccine against coronavirus disease 2019 (COVID-19) which stimulates the body’s immune system without risk of causing disease. Once inactivated viruses get presented to the body’s immune system, they stimulate the production of antibodies and make the body ready to respond to an infection with live SARS-CoV-2. This vaccine is adjuvanted (with aluminum hydroxide), to boost the response of the immune system. A large multi-country phase 3 trial has shown that two doses administered at an interval of 21 days had the efficacy of 79% against symptomatic SARS-CoV-2 infection 14 days or more after the second dose. The trial was not designed and powered to demonstrate efficacy against severe disease. Vaccine efficacy against hospitalization was 79%. The median duration of follow up available at the time of review was 112 days. Two efficacy trials are underway. The data reviewed at this time support the conclusion that the known and potential benefits of Sinopharm vaccine outweigh the known and potential risks. Date of WHO Emergency Use Listing (EUL) recommendation: 7 May 2021 Date of prequalification (PQ): currently no information National regulatory authorities (NRAs) can use reliance approaches for in-country authorization of vaccines based on WHO PQ/EUL or emergency use authorizations by stringent regulatory authorities (SRAs). Product characteristics Presentation Fully liquid, inactivated, adjuvanted, preservative-free suspension in vials and AD pre-filled syringes Number of doses Single-dose (one dose 0.5 mL) Vaccine syringe type Two available presentations: and needle size 1. -
Ion Channels of Nociception
International Journal of Molecular Sciences Editorial Ion Channels of Nociception Rashid Giniatullin A.I. Virtanen Institute, University of Eastern Finland, 70211 Kuopio, Finland; Rashid.Giniatullin@uef.fi; Tel.: +358-403553665 Received: 13 May 2020; Accepted: 15 May 2020; Published: 18 May 2020 Abstract: The special issue “Ion Channels of Nociception” contains 13 articles published by 73 authors from different countries united by the main focusing on the peripheral mechanisms of pain. The content covers the mechanisms of neuropathic, inflammatory, and dental pain as well as pain in migraine and diabetes, nociceptive roles of P2X3, ASIC, Piezo and TRP channels, pain control through GPCRs and pharmacological agents and non-pharmacological treatment with electroacupuncture. Keywords: pain; nociception; sensory neurons; ion channels; P2X3; TRPV1; TRPA1; ASIC; Piezo channels; migraine; tooth pain Sensation of pain is one of the fundamental attributes of most species, including humans. Physiological (acute) pain protects our physical and mental health from harmful stimuli, whereas chronic and pathological pain are debilitating and contribute to the disease state. Despite active studies for decades, molecular mechanisms of pain—especially of pathological pain—remain largely unaddressed, as evidenced by the growing number of patients with chronic forms of pain. There are, however, some very promising advances emerging. A new field of pain treatment via neuromodulation is quickly growing, as well as novel mechanistic explanations unleashing the efficiency of traditional techniques of Chinese medicine. New molecular actors with important roles in pain mechanisms are being characterized, such as the mechanosensitive Piezo ion channels [1]. Pain signals are detected by specialized sensory neurons, emitting nerve impulses encoding pain in response to noxious stimuli. -
Exercise Intensity As a Determinant of Exercise Induced Hypoalgesia Karen Y
Health Sciences Faculty Publications Health Sciences 8-2011 Exercise Intensity as a Determinant of Exercise Induced Hypoalgesia Karen Y. Wonders Wright State University Daniel G. Drury Gettysburg College Follow this and additional works at: https://cupola.gettysburg.edu/healthfac Part of the Exercise Science Commons, Other Medicine and Health Sciences Commons, and the Sports Sciences Commons Share feedback about the accessibility of this item. Wonders, Karen, and Daniel Drury. Exercise Intensity as a Determinant of Exercise Induced Hypoalgesia. Journal of Exercise Physiology (August 2011) 14(4):134-144. This is the publisher's version of the work. This publication appears in Gettysburg College's institutional repository by permission of the copyright owner for personal use, not for redistribution. Cupola permanent link: https://cupola.gettysburg.edu/healthfac/33 This open access article is brought to you by The uC pola: Scholarship at Gettysburg College. It has been accepted for inclusion by an authorized administrator of The uC pola. For more information, please contact [email protected]. Exercise Intensity as a Determinant of Exercise Induced Hypoalgesia Abstract The purpose of this study was to examine pain perception during and following two separate 30-min bouts of exercise above and below the Lactate Threshold (LT). Pain Threshold (PT) and Pain Intensity (PI) were monitored during (15 and 30 min) and after exercise (15 and 30 min into recovery) using a Cold Pressor Test (CPT) and Visual Analog Scale (VAS) for pain of the non-dominant hand. Significant differences in PT scores were found both during and after exercise conditions. Post hoc analysis revealed significant differences in PT scores at 30 min of exercise (P=0.024, P=0.02) and 15 min of recovery (P=0.03, P=0.01) for exercise conditions above and below LT, respectively. -
Martin Steinhoff Dirk Roosterman, Tobias Goerge, Stefan W
Dirk Roosterman, Tobias Goerge, Stefan W. Schneider, Nigel W. Bunnett and Martin Steinhoff Physiol Rev 86:1309-1379, 2006. doi:10.1152/physrev.00026.2005 You might find this additional information useful... This article cites 963 articles, 265 of which you can access free at: http://physrev.physiology.org/cgi/content/full/86/4/1309#BIBL Medline items on this article's topics can be found at http://highwire.stanford.edu/lists/artbytopic.dtl on the following topics: Biochemistry .. Transient Receptor Potential Channel Biochemistry .. Endopeptidases Biochemistry .. Proteolytic Enzymes Oncology .. Inflammation Medicine .. Neurogenic Inflammation Physiology .. Nerves Updated information and services including high-resolution figures, can be found at: http://physrev.physiology.org/cgi/content/full/86/4/1309 Downloaded from Additional material and information about Physiological Reviews can be found at: http://www.the-aps.org/publications/prv This information is current as of February 8, 2008 . physrev.physiology.org on February 8, 2008 Physiological Reviews provides state of the art coverage of timely issues in the physiological and biomedical sciences. It is published quarterly in January, April, July, and October by the American Physiological Society, 9650 Rockville Pike, Bethesda MD 20814-3991. Copyright © 2005 by the American Physiological Society. ISSN: 0031-9333, ESSN: 1522-1210. Visit our website at http://www.the-aps.org/. Physiol Rev 86: 1309–1379, 2006; doi:10.1152/physrev.00026.2005. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ DIRK ROOSTERMAN, TOBIAS GOERGE, STEFAN W. SCHNEIDER, NIGEL W. BUNNETT, AND MARTIN STEINHOFF Department of Dermatology, IZKF Mu¨nster, and Boltzmann Institute for Cell and Immunobiology of the Skin, University of Mu¨nster, Mu¨nster, Germany; and Departments of Surgery and Physiology, University of California, San Francisco, California I. -
A Review of Hyperacusis and Future Directions: Part I. Definitions and Manifestations
AJA Review Article A Review of Hyperacusis and Future Directions: Part I. Definitions and Manifestations Richard S. Tyler,a Martin Pienkowski,b Eveling Rojas Roncancio,a Hyung Jin Jun,a Tom Brozoski,c Nicolas Dauman,d Claudia Barros Coelho,a Gerhard Andersson,e,f Andrew J. Keiner,a Anthony T. Cacace,g Nora Martin,a and Brian C. J. Mooreh Purpose: Hyperacusis can be extremely debilitating, and at Results: Hyperacusis encompasses a wide range of present, there is no cure. We provide an overview of the reactions to sound, which can be grouped into the field, and possible related areas, in the hope of facilitating categories of excessive loudness, annoyance, fear, and future research. pain. Many different causes have been proposed, and it will Method: We review and reference literature on be important to appreciate and quantify different subgroups. hyperacusis and related areas. We have divided the Reasonable approaches to assessing the different forms of review into 2 articles. In Part I, we discuss definitions, hyperacusis are emerging, including psychoacoustical epidemiology, different etiologies and subgroups, and measures, questionnaires, and brain imaging. how hyperacusis affects people. In Part II, we review Conclusions: Hyperacusis can make life difficult for many, measurements, models, mechanisms, and treatments, forcing sufferers to dramatically alter their work and social and we finish with some suggestions for further habits. We believe this is an opportune time to explore research. approaches to better understand and treat hyperacusis. yperacusis can be devastating for those who suf- refereed publications, books, and conference proceedings. fer from it. This review is intended to clarify what We highlighted what we believe are key issues that are im- H is known at present about hyperacusis and its portant to move forward, sometimes even drawing from underlying mechanisms to focus research and to promote areas not normally associated with hyperacusis. -
Chronic Pain: How Challenging Are Ddis in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2017 Chronic pain: how challenging are DDIs in the analgesic treatment of inpatients with multiple chronic conditions? Siebenhuener, Klarissa ; Eschmann, Emmanuel ; Kienast, Alexander ; Schneider, Dominik ; Minder, Christoph E ; Saller, Reinhard ; Zimmerli, Lukas ; Blaser, Jürg ; Battegay, Edouard ; Holzer, Barbara M Abstract: BACKGROUND Chronic pain is common in multimorbid patients. However, little is known about the implications of chronic pain and analgesic treatment on multimorbid patients. This study aimed to assess chronic pain therapy with regard to the interaction potential in a sample of inpatients with multiple chronic conditions. METHODS AND FINDINGS We conducted a retrospective study with all multimorbid inpatients aged 18 years admitted to the Department of Internal Medicine of University Hospital Zurich in 2011 (n = 1,039 patients). Data were extracted from the electronic health records and reviewed. We identified 433 hospitalizations of patients with chronic pain and analyzed their com- binations of chronic conditions (multimorbidity). We then classified all analgesic prescriptions according to the World Health Organization (WHO) analgesic ladder. Furthermore, we used a Swiss drug-drug interactions knowledge base to identify potential interactions between opioids and other drug classes, in particular coanalgesics and other concomitant drugs. Chronic pain was present in 38% of patients with multimorbidity. On average, patients with chronic pain were aged 65.7 years and had a mean number of 6.6 diagnoses. Hypertension was the most common chronic condition. Chronic back pain was the most common painful condition. Almost 90% of patients were exposed to polypharmacotherapy. -
Interview and History Taking Strategies CHAPTER 2 Physical Examination Strategies CHAPTER 3 Documentation Strategies
Part 1 Strategies for Eff ective Health Assessment CHAPTER 1 Interview and History Taking Strategies CHAPTER 2 Physical Examination Strategies CHAPTER 3 Documentation Strategies 1 © Jones & Bartlett Learning, LLC, an Ascend Learning Company. NOT FOR SALE OR DISTRIBUTION 9781284131390_CH01_Pass01.indd 1 24/09/16 12:24 PM Chapter 1 Interview and History Taking Strategies “In taking histories follow each line of thought, ask no leading questions. Never suggest. Give the patient’s own words in the complaint.” Sir William Osler (1849–1919) (Bean & Bean, 1968) Functions of the Interview and Health History Interviewing and taking health histories serve fi ve major functions: 1. Establishing the initial bond between provider and patient (Figure 1-1) 2. Laying the foundation for subsequent clinical decision making 3. Providing a legal record of the subjective and objective data (Box 1-1) elicited during the clinical interview, which drive clinical judgments 4. Fulfi lling a critical component of the documentation required for third-party payer reimbursement for clinical services 5. Serving as an essential element in the peer review process for evaluation of clinical practice, such as application of evidence-based practice and identifi cation of desired patient outcomes As the primary goal of this text is to help the reader to develop expertise in advanced health assessment, this chapter will focus primarily on functions one and two. Legal and reimbursement requirements mandate meticulous, comprehensive, and complete documentation of all the components of care, including patient teaching and counsel- ing provided at each provider–patient encounter. These include not only the traditional face-to-face encounters, but also other means of care, such as interaction via e-mail and telephone.